Clinical Trials Database
Actively Recruiting:
Trial: Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma
Conditions: Mesothelioma
Conditions: Mesothelioma
Trial: Immunotoxin Therapy, Pemetrexed, and Cisplatin in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed by Surgery
Conditions: Malignant Mesothelioma
Conditions: Malignant Mesothelioma
Trial: Dasatinib in Resectable Malignant Pleural Mesothelioma
Conditions: Malignant Pleural Mesothelioma
Conditions: Malignant Pleural Mesothelioma
Trial: Early Diagnosis of Lung Cancer and Mesothelioma in Prior Asbestos Workers
Conditions: Lung Cancer; Mesothelioma
Conditions: Lung Cancer; Mesothelioma
Trial: Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma
Conditions: Malignant Mesothelioma
Conditions: Malignant Mesothelioma
Trial: Pazopanib in Treating Patients With Malignant Pleural Mesothelioma
Conditions: Malignant Mesothelioma
Conditions: Malignant Mesothelioma
Trial: Bortezomib in Treating Patients With Malignant Pleural Mesothelioma
Conditions: Malignant Mesothelioma
Conditions: Malignant Mesothelioma
Trial: AZD2171 in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery
Conditions: Malignant Mesothelioma
Conditions: Malignant Mesothelioma
Trial: Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma
Conditions: Malignant Mesothelioma
Conditions: Malignant Mesothelioma
Trial: Study of CBP501 + Pemetrexed + Cisplatin in Patients With Solid Tumors (Phase I) and Patients With Malignant Pleural Mesothelioma (Phase II)
Conditions: Malignant Pleural Mesothelioma; MPM; Solid Tumors
Conditions: Malignant Pleural Mesothelioma; MPM; Solid Tumors
Trial: Pharmacokinetic, Safety, and Efficacy Effects of Oral LBH589 on Dextromethorphan in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer or Malignant Pleural Mesothelioma
Conditions: Carcinoma, Non-Small-Cell Lung; Mesothelioma
Conditions: Carcinoma, Non-Small-Cell Lung; Mesothelioma
Trial: Pemetrexed Disodium and Cisplatin Followed by Surgery With or Without Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma
Conditions: Malignant Mesothelioma
Conditions: Malignant Mesothelioma
Trial: Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma
Conditions: Malignant Mesothelioma
Conditions: Malignant Mesothelioma
Trial: Dendritic Cell-Based Immunotherapy in Mesothelioma
Conditions: Malignant Pleural Mesothelioma
Conditions: Malignant Pleural Mesothelioma
Trial: Study of Patients With Non-Small Cell Lung Cancer, Esophageal Cancer, or Malignant Pleural Mesothelioma
Conditions: Esophageal Cancer; Lung Cancer; Malignant Mesothelioma
Conditions: Esophageal Cancer; Lung Cancer; Malignant Mesothelioma
Trial: Combination Chemotherapy With or Without Surgery and Radiation Therapy in Treating Patients With Mesothelioma That Can Be Removed By Surgery
Conditions: Malignant Mesothelioma
Conditions: Malignant Mesothelioma
Trial: Pemetrexed, Cisplatin, and Vitamin B12 in Treating Patients With Mesothelioma of the Chest That Cannot Be Removed by Surgery
Conditions: Malignant Mesothelioma
Conditions: Malignant Mesothelioma
Trial: Cisplatin, Pemetrexed and Bevacizumab for Untreated Malignant Mesothelioma
Conditions: Mesothelioma
Conditions: Mesothelioma
Trial: An Efficacy and Safety Study With Vandetanib to Treat Inoperable or Relapsed Malignant Mesothelioma
Conditions: Mesothelioma
Conditions: Mesothelioma
Trial: Study of Carboplatin and Vinorelbine in Malignant Pleural Mesothelioma
Conditions: Malignant Pleural Mesothelioma
Conditions: Malignant Pleural Mesothelioma
Trial: Vorinostat (MK0683, SAHA) Versus Placebo in Advanced Malignant Pleural Mesothelioma
Conditions: Mesothelioma; Lung Cancer
Conditions: Mesothelioma; Lung Cancer
